Exomind for Anxiety Disorders
Exomind (rTMS) for anxiety disorders — an emerging application with growing but still developing evidence, discussed honestly alongside established first-line treatments.
Anxiety disorders are highly treatable with well-established first-line approaches — particularly Cognitive Behavioural Therapy and, where appropriate, medication. rTMS for primary anxiety disorders is an area of growing but still developing research, and is discussed here honestly, distinguishing it from the stronger evidence base for depression.
Dr. Muhammad Shoaib Zafar provides individualised guidance on where rTMS may have a role for patients with anxiety, always within the context of established, first-line treatment.
Current State of the Evidence
Research into rTMS for generalised anxiety disorder and related conditions is ongoing, with some encouraging findings, particularly for anxiety occurring alongside depression (sometimes referred to as 'anxious depression'), but the evidence base for anxiety disorders as a primary, standalone indication is considerably less developed than for depression, and rTMS does not currently have specific regulatory clearance for this indication.
Where rTMS May Have a Role
For patients with significant anxiety occurring alongside treatment-resistant depression, rTMS targeting depression may also produce meaningful improvement in co-existing anxiety symptoms, given the overlapping brain circuits involved.
First-Line Treatment Remains Essential
For most patients with a primary anxiety disorder, Cognitive Behavioural Therapy and, where appropriate, medication remain the established first-line treatments, and should generally be tried before considering rTMS for anxiety specifically.
Frequently Asked Questions
Frequently Asked Questions
Is rTMS FDA-cleared for anxiety disorders?
No, unlike depression and OCD, rTMS does not currently have specific FDA clearance for primary anxiety disorders as a standalone indication.
Should I try rTMS before CBT for anxiety?
Generally, no — CBT is the established first-line treatment for most anxiety disorders and should typically be tried first, with rTMS considered as an emerging option in more complex or treatment-resistant presentations.
Expert Care
Dr. Muhammad Shoaib Zafar provides honest, individualised guidance on the current, evolving role of rTMS for anxiety, always prioritising established first-line treatment.
This page is provided for general educational purposes and does not replace an individual psychiatric assessment.
Common signs & symptoms
- Persistent, excessive worry
- Physical symptoms of anxiety
- Panic attacks
- Avoidance behaviour
- Difficulty concentrating due to anxiety
Treatment approach
- → Considered alongside, not instead of, first-line CBT and medication for most anxiety disorders
- → May be considered for anxiety occurring alongside depression
- → Individualised assessment to determine suitability
Frequently asked questions
Is rTMS FDA-cleared for anxiety disorders?
No, unlike depression and OCD, rTMS does not currently have specific FDA clearance for primary anxiety disorders as a standalone indication.
Should I try rTMS before CBT for anxiety?
Generally, no — CBT is the established first-line treatment for most anxiety disorders and should typically be tried first, with rTMS considered as an emerging option in more complex or treatment-resistant presentations.